The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia
Clinical trial NCT02844322 · COMPLETED
Trial details
- NCT number
- NCT02844322
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2022-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.